Literature DB >> 2914284

Esophageal squamous cell carcinoma associated with gastric adenocarcinoma.

J C Souquet1, F Berger, S Bonvoisin, C Partensky, J Boulez, F Descos, R Lambert.   

Abstract

Adenocarcinoma of the stomach occurred in six of 425 consecutive patients with esophageal squamous cell cancer. In two cases, the gastric cancer, which was recognized at 17 and 29 months, respectively, after the nonsurgical treatment of the esophageal tumor, was treated by surgical resection. In three cases, the tumors which were diagnosed simultaneously, were treated by surgery (one case) resection of the gastric tumor and nonsurgical therapy for the esophageal tumor (one case), and nonsurgical therapy for both tumors (one case). In one case, a gastric cancer was resected 6 years before diagnosis of an esophageal tumor and a second cancer in the gastric stump. A nonsurgical protocol was then adopted for both tumors. The association of these two cancers raises questions concerning their epidemiology, diagnosis, prognosis, and management. There is room for nonsurgical multimodality protocols and, in association with surgery, survival was prolonged for more than 1 year in five of six patients.

Entities:  

Mesh:

Year:  1989        PMID: 2914284     DOI: 10.1002/1097-0142(19890215)63:4<786::aid-cncr2820630430>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Metachronous adenocarcinoma in a gastric tube after radical surgery for oesophageal cancer.

Authors:  Justyna Izabela Zygoń; Jarosław Skokowski; Jacek Zieliński; Kamil Drucis; Katarzyna Golabek-Dropiewska
Journal:  BMJ Case Rep       Date:  2010-03-11

2.  Squamous cell carcinoma of the esophagus and adenocarcinoma of gastroesophageal junction, a rare coincidence.

Authors:  B Geramizadeh; A Safari; F Javadi; Sh Bolandparvaz
Journal:  Iran Red Crescent Med J       Date:  2011-07-01       Impact factor: 0.611

3.  Endoscopic resection for synchronous esophageal squamous cell carcinoma and gastric adenocarcinoma in early stage is a possible alternative to surgery.

Authors:  Se Jeong Park; Ji Yong Ahn; Hwoon Yong Jung; Shin Na; So Eun Park; Mi Young Kim; Kwi Sook Choi; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin Ho Kim; Seungbong Han
Journal:  Gut Liver       Date:  2015-01       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.